| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 744025 | diethyl 2-[4-(5-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypentyl)piperazino]ethylphosphonate | 0.0181211508101519 | 0.32606206 |
| NSC 763186 | Null | 0.0181211508101519 | 0.27417451 |
| NSC 668261 | Null | 0.0185619722391416 | 0.6898253 |
| NSC 710552 | Null | 0.0199123109106645 | 0.058385031 |
| NSC 750493 | 2-(2-hydroxyphenyl)-3-[5-(1H-imidazol-1-ylmethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazolidin-4-one | 0.0199123109106645 | 0.54748164 |
| NSC 754664 | 3-amino-N-(5-chloro-2-methylphenyl)-5-oxo-5,6,7,8-tetrahydrothieno[2,3-b]quinoline-2-carboxamide | 0.0199123109106645 | 0.028688418 |
| NSC 762889 | 6-Chloro-5-[2-(piperazin-1-yl)ethyl]-1,3-dihydro-2H-indol-2-one | 0.0199123109106645 | 0.082846472 |
| NSC 93301 | Null | 0.0199123109106645 | 0.009831606 |
| NSC 113497 | 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) | 0.0209467683758286 | 0.14889648 |
| NSC 129794 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) | 0.0209467683758286 | 0.23753654 |